A26D (p.Ala26Asp) variant of GFAP (Glial fibrillary acidic protein)

A26D (p.Ala26Asp) in GFAP (Glial fibrillary acidic protein) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.35 / 1. The record also includes population frequency data.

A26D (p.Ala26Asp) variant details